News & Updates
Filter by Specialty:
Ketogenic trials with Parkinson’s disease-specific outcomes lacking
The ketogenic diet, as well as ketogenic agents, has been shown to be a promising therapeutic regimen for Parkinson’s disease (PD) in animals, but research on humans is highly heterogenous and lacking PD-specific outcomes, according to a study.
Ketogenic trials with Parkinson’s disease-specific outcomes lacking
19 Jun 2022Pandemic-caused treatment delays for cancer may aggravate psychological distress
Cancer patients who experience treatment delays due to the COVID-19 pandemic restrictions may be vulnerable to psychological distress, reports a recent China study. Effective communication from doctors and other cancer care professionals may help mitigate this effect.
Pandemic-caused treatment delays for cancer may aggravate psychological distress
18 Jun 2022Dulaglutide: A new horizon for T2D treatment in kids
A once-weekly subcutaneous dose of the GLP-1* receptor agonist dulaglutide successfully controlled glycaemic levels in youths with type 2 diabetes (T2D) being treated with lifestyle modification with or without metformin or insulin, results of the multinational, phase III AWARD-PEDS** study showed.
Dulaglutide: A new horizon for T2D treatment in kids
18 Jun 2022Estimated pulse wave velocity, socioeconomic status predict stroke risk in men
Estimated pulse wave velocity (ePWV) and socioeconomic status (SES) independently contribute to a higher risk of stroke in men, and the relationship between elevated ePWV and increased stroke risk remains whether an individual has high or low SES, according to a study.
Estimated pulse wave velocity, socioeconomic status predict stroke risk in men
18 Jun 2022LDL-C properly managed in older T2DM patients
Regardless of the use of medication, levels of low-density lipoprotein cholesterol (LDL-C) appear to be appropriately managed in older type 2 diabetes mellitus (T2DM) patients, contributing to the prevention of coronary artery disease (CAD), a recent study has found.